GRANIX
Total Payments
$129,261
Transactions
403
Doctors
222
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $40.16 | 2 | 2 |
| 2019 | $17,072 | 26 | 15 |
| 2018 | $19,098 | 175 | 88 |
| 2017 | $93,052 | 200 | 137 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $99,450 | 34 | 76.9% |
| Consulting Fee | $20,975 | 5 | 16.2% |
| Food and Beverage | $6,240 | 354 | 4.8% |
| Travel and Lodging | $2,596 | 10 | 2.0% |
Payments by Type
Research
$99,450
34 transactions
General
$29,811
369 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TV44688-ONC-30054 | Teva Pharmaceuticals USA, Inc. | $68,475 | 0 |
| Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants (GRANIX) | Teva Pharmaceuticals USA, Inc. | $16,675 | 0 |
| XM02-ONC-201 | Teva Pharmaceuticals USA, Inc. | $14,300 | 0 |
Top Doctors Receiving Payments for GRANIX — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology & Oncology | Manasquan, NJ | $28.58 | 2 |
| , MD | Hematology & Oncology | Manasquan, NJ | $28.58 | 2 |
| , MD | Internal Medicine | Conroe, TX | $28.54 | 2 |
| , DO | Rheumatology | The Woodlands, TX | $26.69 | 1 |
| , MD | Specialist | Kingston, NY | $26.65 | 2 |
| , D.O | Medical Oncology | Houston, TX | $26.17 | 1 |
| , DO | Hematology & Oncology | Lubbock, TX | $25.82 | 1 |
| , M.D | Medical Oncology | Beverly Hills, CA | $24.70 | 1 |
| , M.D | Hematology & Oncology | New York, NY | $24.55 | 2 |
| , MD | Internal Medicine | Kingwood, TX | $24.28 | 1 |
| , MD | Internal Medicine | Reno, NV | $24.05 | 1 |
| James Forsythe | — | Reno, NV | $24.05 | 1 |
| Steven Young | — | Somerville, NJ | $23.77 | 2 |
| , MD | Radiation Oncology | Anderson, IN | $23.70 | 2 |
| , MD | Internal Medicine | Anderson, IN | $23.70 | 2 |
| , MD | Hematology & Oncology | Chicago, IL | $22.39 | 1 |
| , M.D | Hematology & Oncology | New York, NY | $22.23 | 1 |
| , M.D | Internal Medicine | Voorhees, NJ | $21.82 | 1 |
| , MD | Hematology & Oncology | Voorhees, NJ | $21.82 | 1 |
| , D.O | Hematology & Oncology | Hialeah, FL | $21.38 | 2 |
| , M.D | Hematology & Oncology | Flushing, NY | $21.32 | 1 |
| , M.D | Hematology & Oncology | New Hartford, NY | $21.31 | 2 |
| , M.D | Internal Medicine | Santa Ana, CA | $21.09 | 1 |
| Shilpa Shah | Internal Medicine | Oxnard, CA | $20.65 | 1 |
| , M.D | Hematology & Oncology | La Jolla, CA | $19.69 | 1 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $129,261
Product Information
- Type Drug
- Total Payments $129,261
- Total Doctors 222
- Transactions 403
About GRANIX
GRANIX is a drug associated with $129,261 in payments to 222 healthcare providers, recorded across 403 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2020. In 2020, $40.16 was paid across 2 transactions to 2 doctors.
The most common payment nature for GRANIX is "Unspecified" ($99,450, 76.9% of total).
GRANIX is associated with 3 research studies, including "TV44688-ONC-30054" ($68,475).